Other
Conventional glycemic control
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Completion Rate
0%(0/2)
Active Trials
0(0%)
Terminated
2(67%)
Phase Distribution
Ph phase_3
1
33%
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 2 finished
Non-Completion Rate
100.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Terminated(2)
Other(1)
Detailed Status
Terminated2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (33.3%)
N/A2 (66.7%)
Trials by Status
terminated267%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
Clinical Trials (3)
Showing 3 of 3 trials
NCT00353275Not Applicable
Hyperglycemia in Surgical Infections
NCT00487162Not Applicable
The Association Between Peri-Operative Hyperglycemia and Major Morbidity and Mortality
NCT00591071Phase 3
Impact of 2 Blood Glucose Levels on Hospital Mortality in Patients Admitted in ICU
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3